Rosetta Genomics (ROSG)

Add to Watchlists Create an Alert
3.72 -0.04  -1.06% NASDAQ Aug 22, 8:00PM BATS Real time Currency in USD
View Full Chart
ROSG Price Chart
View All Events

ROSG Events

Date Type Description
04/01/2014 10:00 EDT Misc Rosetta Genomics, Ltd. Q4 2013 Earning Conference Call
03/31/2014 Earnings Rosetta Genomics, Ltd. Q4 2013 Earning Result
09/10/2013 10:00 EDT Misc Rosetta Genomics to Host Business Update Conference Call on September 10, 2013
09/09/2013 Earnings Rosetta Genomics Announces Q2 2013 Results
View All Performance Charts

ROSG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Rosetta Genomics is up 11.04% over the last year vs S&P 500 Total Return up 22.53%, BG Medicine down 8.70%, and LipoScience down 41.77%.

Get Quote for

Portfolio Strategies Featuring ROSG

Did Rosetta Genomics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ROSG Profile

Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic tests and therapeutics based on a group of genes known as microRNAs.

ROSG Excel Add-In Codes

  • Name: =YCI("ROSG","name")
  • Description: =YCI("ROSG","description")
  • Sector: =YCI("ROSG","sector")
  • Industry: =YCI("ROSG","industry")
  • Est. Current Fiscal Year End: =YCI("ROSG","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.